The behavioral performance tests of Mucuna pruriens gold nanoparticles in the 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine treated mouse model of Parkinsonism

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue SUPPL.1, 2012, Pages

  Arulkumar, Subramanian ^a   Sabesan, Muthukumaran ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Goldnanoparticles; Hang test; MPTP; Mucuna pruriens; Narrowbeam mase; Parkinson's disease; Rotarod

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CHLOROAURICCHLORIDE; GOLD NANOPARTICLE; HERBACEOUS AGENT; METHANOL; MUCUNA PRURIENS EXTRACT; REAGENT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG RESPONSE; DRUG SYNTHESIS; EXPERIMENTAL MOUSE; HAND TEST; MALE; MOUSE; NARROW BEAM TEST; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PLANT SEED; POWDER; PRIORITY JOURNAL; ROTAROD TEST; VELVET BEAN;

EID: 84869111154     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60210-2     Document Type: Article

References (29)

1. Pahwa R, Lyons KE Early diagnosis of Parkinson's disease:recommendations from diagnostic clinical guidelines. Am J Manag Care 2010, 16:S94-S99.
2. Hickey P, Stacy M Available and emerging treatments for Parkinson's disease: a review. Drug Des Devel Ther. 2011, 5:241-254.
3. Chen JJ Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment. Am J Manag Care 2010, 16:S87-S93.
4. Dhanasekaran M, Karuppagounder SS, Uthayathas S, Wold LE, Parameshwaran K, Jayachandra Babu R, Suppiramaniam V, Brown-Borg H Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content. Life Sciences 2008, 83:92-95.
5. Bhushan P, Ashok DBV Natural products drug discovery: Accelerating the clinical candidate development using reverse pharmacology approaches. Indian Journal of Experimental Biology. 2010, 48:220-227.
6. Vijaya Sree N, Udayasri P, Kumar YVV Aswani, Ravi Babu B, Phani Kumar Y, Vijay Varma M Advancements in the Production of Secondary Metabolites. Journal of Natural Products. 2010, 3:112-123.
7. Modi G, Pillay V Choonara YE, Ndesendo VMK, Toit LC, Naidoo D. Nanotechnological applications for the treatment of neurodegenerative disorders. Progress in Neurobiology 2009, 88:272-285.
8. De Jong Wim H, Borm Paul JA Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomedicine 2011, 3(2):133-149.
9. Bartneck M, Keul HA, Singh S, et al. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. Nanotechnology 2010, 6:3073-3086.
10. Vithiya K, Sen S Biosynthesis of Nanoparticles. International Journal of Pharmaceutical Sciences and Research 2011, 2(11):2781-2785.
11. Venkatesan S, Karthiga S, Kirithika M, Ganesan R, Muthuchelian K A novel approach for the microbial production and optimization of gold nanoparticles - an alternate approach to chemical synthesis. International Journal of Applied Biology and Pharmaceutical Technology 2011, 2(3):165-177.
12. Andeani JK, Kazemi H, Mohsenzadeh S, Safavi A Biosynthesis of Gold Nanoparticles using dried flowers extract of Achillea Wilhelmsii Plant. Digest Journal of Nanomaterials and Biostructures. 2011, 6(3):1011-1017.
13. Nagajyoti PC, Prasad TNVK, Sreekanth TVM, Kapduk L Bio-Fabrication of Silver Nanoparticles Using Leaf Extract of Saururus Chinenis. Digest Journal of Nanomaterials and Biostructures 2011, 6(1):121-133.
14. Arulkumar S, Sabesan M Biosynthesis and characterization of gold nanoparticle using antiparkinsonian drug Mucuna pruriens plant extract. Int. J. Res. Pharm. Sci. 2010, 1:417-420.
15. Araki T, Kumagai T, Tanaka K, Matsubara M, Kato H, Itoyama Y, Imai Y Neuro protective effect of riluzolein MPTP-treated mice. Brain Res 2001, 918:176-181.
16. Rozas G, Lopez-martin E, Guerra MJ, Labanderia-Garcia JL The overall rod performance test in the MPTP-treated mouse model of parkinsonism. J. Neurosci. Methods 1998, 83:165-175.
17. Lalonde R, Joyal CC, Thiffault S Beam sensorimotor learning and habituation to motor activity in lurched mutant mice. Behav. Brain Res. 1996, 74:87-92.
18. Tillerson JL, Miller GW Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism. J Neurosci Methods 2003, 123:189-200.
19. Malagelada C, Jin Z, Jackson-Lewis V, Przedborski S, Greene L Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson'sdisease. J Neurosci 2010, 30:1166-1175.
20. Goldberg NRS, Haack AK, Lim NS, Janson OK, Meshul CK Dopaminergic and behavioral correlates of a progressive mouse model of Parkinson'sdisease. Neuroscience 2011, 180:256-271.
21. Dhanasekaran S, Ratheeshkumar KS, Palayan M Effect of ethanolic seed extract of Mucuna pruriens (l.) dc.var. Utilis on haloperidol induced tardive dyskinesia in rats 2010, 3(2):106-113.
22. Sathyanarayana N, Bharath kumar TN, Vikas PB, Rajesha R In vitro clonal propagation of Mucuna pruriens var. utilis and its evaluation of genetic stability through RAPD markers. African Journal of Biotechnology 2008, 7(8):973-980.
23. Vinoth Kumar Megraj K, Raju K, Balaraman R, Meenakshisundaram K Biological Activities of Some Indian medicinal plants. Journal of Advanced Pharmacy Education & Research. 2011, 1:12-44.
24. Maheswari T, Vijayrajaa D, Kundhavai Natchiyar R, Kalaivani K, Rajasankar S, Tamilselvam K, Manivasagam T Synergistic neuropreventive effect of Withania somnifera root powder and Mucuna pruriens seed Powder in parkinsonic mice model. Journal of Herbal Medicine and Toxicology 2010, 4(2):63-69.
25. Madhavi RB, Vidya VD Synthesis of Gold Nano particles using Putranjiva roxburghii Wall. leaves Extract. Int. J. of Drug Discovery & Herbal Research 2012, 2(1):275-278.
26. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochemical and Biophysical Research Communications. 2010, 393:649-655.
27. Rempe R., Cramer S., Galla H. Transport of poly (n-butycyano-acrylate) nanoparticles across the blood brain barrier in vitro and their influence on barrier integrity. Biochemical Biophysical Research Communications 2011, 406(1):64-69.
28. Spuch C, Antequera D, Portero A, Orive G, Hernandez R, Molina J, Bermejo-Pareja F, Pedraz J, Carro E The effect of encapsulated VEGF secreting cells on brain amyloid load and behavioural impairment in a mouse model of Alzheimer's disease. Biomaterials 2010, 31(21):5608-5618.
29. Sahni J, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C Neurotherapeutic applications of nanoparticles in Alzheimer's disease. Journal of Controled Release 2011, 152:208-231.